Physician

Baher M Elhalwagi, MD

According to 2025 Medicare claims, Baher Elhalwagi, MD (NPI: 1235116393) practices pulmonary disease in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is EAST TEXAS PULMONARY ASSOCIATES OF LONGVIEW, PLLC (NPI: 1407932510; TIN: 752799006) and primary practice location at 75601-5580. Elhalwagi is affiliated with the CHRISTUS Health Quality Care Alliance (ACO ID: A3029), participating under the MSSP model.

Elhalwagi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 934 traditional Medicare patients, billed 3,825 HCPCS/CPT codes, and received $262,100 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 1,362 prescription claims across 254 beneficiaries totaling $577,802 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 3,281 claims. Open Payments data shows 25 records totaling $530. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $178,639 to $577,802. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,400	6,993	$425,388
2016	1,261	6,220	$394,348
2017	1,230	5,894	$373,390
2018	1,098	6,166	$410,014
2019	1,095	5,454	$361,468
2020	1,150	6,529	$431,145
2021	1,170	5,960	$408,960
2022	1,064	5,438	$355,707
2023	1,049	5,282	$367,084
2024	934	3,825	$262,100

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	193	955	$178,639
2016	175	897	$176,538
2017	186	877	$174,603
2018	197	1,044	$242,330
2019	215	1,184	$298,213
2020	202	1,158	$325,121
2021	210	1,075	$394,929
2022	220	1,203	$573,162
2023	267	1,429	$680,866
2024	254	1,362	$577,802

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,935	4,705	$260,278
2016	2,147	5,347	$193,254
2017	2,154	5,016	$137,877
2018	2,036	4,726	$141,517
2019	2,102	4,675	$141,245
2020	1,862	4,362	$160,901
2021	1,651	3,881	$157,562
2022	1,635	3,920	$165,589
2023	1,566	3,543	$165,710
2024	1,422	3,281	$153,459

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	221	1,132	$82
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	464	568	$77
94726	Test to determine lung volumes using sensors	225	242	$36
94729	Test to examine how well the lungs exchange gases	237	256	$35
94010	Test to measure expiratory airflow and volume	269	289	$16

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	490	18,480	$395,630
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	78	2,820	$58,380
Breo Ellipta	Fluticasone/Vilanterol	45	1,590	$20,543
Symbicort	Budesonide/Formoterol Fumarate	49	2,080	$14,527
Spiriva Handihaler	Tiotropium Bromide	26	780	$13,091

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	12	$24,506
A7030	Full face mask used with positive airway pressure device, each	N	130	275	$22,593
A7031	Face mask interface, replacement for full face mask, each	N	129	282	$19,292
E0601	Continuous positive airway pressure (cpap) device	Y	98	537	$17,204
A7032	Cushion for use on nasal mask interface, replacement only, each	N	68	141	$12,824

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$530	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Baher M. Elhalwagi, MD?

Tedicare shows public-source Medicare data for Baher M. Elhalwagi, MD (NPI 1235116393), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Baher M. Elhalwagi, MD have ACO affiliation data?

Baher M. Elhalwagi, MD is shown with ACO affiliation data for CHRISTUS Health Quality Care Alliance (MSSP, ACO ID A3029).

What billing organization is linked to Baher M. Elhalwagi, MD?

Baher M. Elhalwagi, MD is linked to EAST TEXAS PULMONARY ASSOCIATES OF LONGVIEW, PLLC (billing NPI 1407932510) in the available physician profile data.

Does Baher M. Elhalwagi, MD have Open Payments data?

Baher M. Elhalwagi, MD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.